Access to new diagnostic procedures and therapies

We pay special attention to patients who have experienced a relapse after standard therapy or who continue to progress. Our aim is to include these patients in clinical trials to gain access to new diagnostic and therapeutic procedures.

Our multidisciplinary team at the "KiTZ Clinical Trial Unit (ZIPO)" looks after young patients whose cancer cannot be defeated by standard therapy. The KiTZ Clinical Trial Unit is headed by Professor Olaf Witt (Director of the Translational Program).


Further information: